Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16901-16950 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03241706
Liver Glycogen and Hypoglycemia in Humans
PHASE1
Active, not recruiting
40 participants
Started: Aug 2, 2018 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT03610737
The MOTION Study - Treatment of LSS With the MILD Procedure
NA
Active, not recruiting
155 participants
Started: Aug 2, 2018 · Completed: Apr 30, 2025
1 condition
1 sponsor
18 locations
NCT03853655
Adjuvant Radiotherapy in Early Stage Oral Cancers
NA
Active, not recruiting
392 participants
Started: Aug 2, 2018 · Completed: Sep 30, 2026
5 conditions
2 sponsors
8 locations
NCT03523546
Oncology Episode Payment Model in Hawaii
NA
Active, not recruiting
7 participants
Started: Aug 1, 2018 · Completed: Jan 31, 2026
3 conditions
2 sponsors
1 location
NCT03523585
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
PHASE3
Active, not recruiting
608 participants
Started: Aug 1, 2018 · Completed: Jul 31, 2025
1 condition
3 sponsors
227 locations
NCT03605550
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
PHASE1
Active, not recruiting
64 participants
Started: Aug 1, 2018 · Completed: Mar 1, 2029
2 conditions
2 sponsors
10 locations
NCT03385655
Prostate Cancer Biomarker Enrichment and Treatment Selection
PHASE2
Active, not recruiting
200 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2025
1 condition
3 sponsors
11 locations
NCT03868384
The Effect of Home Blood Pressure Measurement on the Management of Hypertension
N/A
Active, not recruiting
701 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT04814355
The Effect of Celecoxib on Neuroinflammation in MDD
PHASE4
Active, not recruiting
42 participants
Started: Aug 1, 2018 · Completed: Feb 28, 2026
2 conditions
2 sponsors
1 location
NCT03430401
Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia
NA
Active, not recruiting
60 participants
Started: Aug 1, 2018 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT03620578
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL
PHASE2
Active, not recruiting
97 participants
Started: Aug 1, 2018 · Completed: Oct 31, 2026
5 conditions
1 sponsor
24 locations
NCT03563131
Tibial and Femoral Components Migration and Adaptive Bone Remodeling After Insertion of Persona® TKA
NA
Active, not recruiting
66 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03626103
Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents
NA
Active, not recruiting
800 participants
Started: Aug 1, 2018 · Completed: Feb 28, 2025
2 conditions
2 sponsors
2 locations
NCT03924830
Influence of Surface Sealants on the Quality of Posterior Restorations With Bulk Fill Composites
NA
Active, not recruiting
53 participants
Started: Aug 1, 2018 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT03604302
Evaluation of Preoperative Functional Magnetic Resonance Imaging (fMRI) in Patients With Brain Tumors
NA
Active, not recruiting
33 participants
Started: Aug 1, 2018 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT03041610
Pedometer-Based Walking Intervention in Patients With Chronic Heart Failure With Reduced Ejection Fraction
NA
Active, not recruiting
202 participants
Started: Aug 1, 2018 · Completed: Dec 30, 2023
1 condition
6 sponsors
1 location
NCT04287465
Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode
N/A
Active, not recruiting
30 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03638375
TIL and Anti-PD1 in Metastatic Melanoma
PHASE1/PHASE2
Active, not recruiting
34 participants
Started: Jul 31, 2018 · Completed: Nov 29, 2025
3 conditions
2 sponsors
1 location
NCT03540420
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
PHASE2
Active, not recruiting
212 participants
Started: Jul 31, 2018 · Completed: Apr 1, 2027
1 condition
45 sponsors
41 locations
NCT03523416
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
NA
Active, not recruiting
71 participants
Started: Jul 31, 2018 · Completed: Nov 30, 2028
1 condition
1 sponsor
15 locations
NCT03927768
Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)
N/A
Active, not recruiting
264 participants
Started: Jul 31, 2018 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT03599765
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
PHASE2
Active, not recruiting
380 participants
Started: Jul 31, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
12 locations
NCT03431935
Predictors and Outcomes in Patients With Sickle Cell Disease
N/A
Active, not recruiting
94 participants
Started: Jul 31, 2018 · Completed: Jan 31, 2026
1 condition
4 sponsors
2 locations
NCT02454907
The Use of Technology to Improve MS Clinical Trials and Patient Care
NA
Active, not recruiting
150 participants
Started: Jul 31, 2018 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT03433469
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
PHASE2
Active, not recruiting
27 participants
Started: Jul 31, 2018 · Completed: Oct 31, 2026
7 conditions
2 sponsors
3 locations
NCT03543098
STaR Trial: Multiple Ligament Knee Injuries
NA
Active, not recruiting
690 participants
Started: Jul 31, 2018 · Completed: Jun 30, 2027
2 conditions
31 sponsors
1 location
NCT03504241
Tolerance by Engaging Antigen During Cellular Homeostasis
PHASE1
Active, not recruiting
8 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2029
3 conditions
4 sponsors
1 location
NCT03412812
A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain Metastases
NA
Active, not recruiting
13 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04862117
Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)
NA
Active, not recruiting
14 participants
Started: Jul 28, 2018 · Completed: Dec 8, 2026
1 condition
1 sponsor
4 locations
NCT03168516
Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants
PHASE3
Active, not recruiting
1,065 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
32 locations
NCT03630289
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
NA
Active, not recruiting
12 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT03502668
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
PHASE1/PHASE2
Active, not recruiting
160 participants
Started: Jul 27, 2018 · Completed: Dec 1, 2025
1 condition
1 sponsor
29 locations
NCT03607422
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
PHASE3
Active, not recruiting
912 participants
Started: Jul 27, 2018 · Completed: Nov 4, 2025
1 condition
1 sponsor
196 locations
NCT03568058
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
PHASE1
Active, not recruiting
30 participants
Started: Jul 26, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03908788
Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy
NA
Active, not recruiting
130 participants
Started: Jul 26, 2018 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT03500991
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
PHASE1
Active, not recruiting
10 participants
Started: Jul 26, 2018 · Completed: Jul 26, 2039
9 conditions
1 sponsor
1 location
NCT03597165
Incidental Genomics
NA
Active, not recruiting
289 participants
Started: Jul 25, 2018 · Completed: Oct 1, 2027
1 condition
1 sponsor
3 locations
NCT03285789
Dyslexics' Visual Attention Field
NA
Active, not recruiting
1,460 participants
Started: Jul 25, 2018 · Completed: Oct 21, 2026
1 condition
1 sponsor
1 location
NCT03336606
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
PHASE1
Active, not recruiting
35 participants
Started: Jul 25, 2018 · Completed: Dec 1, 2026
5 conditions
3 sponsors
1 location
NCT03654131
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
PHASE2
Active, not recruiting
100 participants
Started: Jul 25, 2018 · Completed: Dec 3, 2029
2 conditions
1 sponsor
1 location
NCT03143322
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NA
Active, not recruiting
168 participants
Started: Jul 24, 2018 · Completed: Jul 22, 2027
4 conditions
1 sponsor
28 locations
NCT03480776
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
PHASE2
Active, not recruiting
117 participants
Started: Jul 24, 2018 · Completed: Sep 15, 2026
1 condition
2 sponsors
17 locations
NCT03573700
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Active, not recruiting
24 participants
Started: Jul 24, 2018 · Completed: Jul 1, 2025
2 conditions
1 sponsor
1 location
NCT03792867
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
NA
Active, not recruiting
5 participants
Started: Jul 23, 2018 · Completed: Mar 31, 2024
1 condition
1 sponsor
1 location
NCT03492177
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
PHASE2
Active, not recruiting
63 participants
Started: Jul 23, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
34 locations
NCT03686748
Two Point Discrimination
EARLY_PHASE1
Active, not recruiting
60 participants
Started: Jul 21, 2018 · Completed: Jul 16, 2027
6 conditions
1 sponsor
1 location
NCT03439735
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC
PHASE2
Active, not recruiting
45 participants
Started: Jul 20, 2018 · Completed: Nov 1, 2026
1 condition
3 sponsors
1 location
NCT03237780
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
PHASE2
Active, not recruiting
72 participants
Started: Jul 20, 2018 · Completed: Jun 30, 2027
24 conditions
1 sponsor
21 locations
NCT03354390
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
PHASE1
Active, not recruiting
17 participants
Started: Jul 20, 2018 · Completed: Mar 3, 2026
1 condition
2 sponsors
1 location
NCT03503630
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
PHASE2
Active, not recruiting
44 participants
Started: Jul 20, 2018 · Completed: Jul 2, 2024
1 condition
3 sponsors
3 locations
Previous
1
More pages
336
337
338
339
340
341
342
More pages
431
Next